Literature DB >> 18624981

Activated thrombin-activatable fibrinolysis inhibitor is generated in vivo at levels that can substantially affect fibrinolysis in chimpanzees in response to thrombin generation.

P Y G Kim, P Y Kim, H Hoogendorn, A R Giles, M E Nesheim.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18624981      PMCID： PMC2574675          DOI： 10.1111/j.1538-7836.2008.03067.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  16 in total

1.  A study of the protection of plasmin from antiplasmin inhibition within an intact fibrin clot during the course of clot lysis.

Authors:  Mark Schneider; Michael Nesheim
Journal:  J Biol Chem       Date:  2004-01-08       Impact factor: 5.157

2.  Carboxypeptidase U (TAFIa) activity is induced in vivo in ischemic stroke patients receiving thrombolytic therapy.

Authors:  J L Willemse; R Brouns; E Heylen; P P De Deyn; D F Hendriks
Journal:  J Thromb Haemost       Date:  2007-10-15       Impact factor: 5.824

3.  D-Phe-Pro-Arg-chloromethylketone: its potential use in inhibiting the formation of in vitro artifacts in blood collected during tissue-type plasminogen activator thrombolytic therapy.

Authors:  M A Mohler; C J Refino; S A Chen; A B Chen; A J Hotchkiss
Journal:  Thromb Haemost       Date:  1986-10-21       Impact factor: 5.249

4.  The fibrinolytic potential of the normal primate following the generation of thrombin in vivo.

Authors:  A R Giles; M E Nesheim; S W Herring; H Hoogendoorn; D C Stump; C M Heldebrant
Journal:  Thromb Haemost       Date:  1990-06-28       Impact factor: 5.249

5.  Two naturally occurring variants of TAFI (Thr-325 and Ile-325) differ substantially with respect to thermal stability and antifibrinolytic activity of the enzyme.

Authors:  Mark Schneider; Michael Boffa; Ronald Stewart; Mona Rahman; Marlys Koschinsky; Michael Nesheim
Journal:  J Biol Chem       Date:  2001-10-29       Impact factor: 5.157

6.  Characterization of plasmin-mediated activation of plasma procarboxypeptidase B. Modulation by glycosaminoglycans.

Authors:  S S Mao; C M Cooper; T Wood; J A Shafer; S J Gardell
Journal:  J Biol Chem       Date:  1999-12-03       Impact factor: 5.157

7.  Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin.

Authors:  M Hoylaerts; D C Rijken; H R Lijnen; D Collen
Journal:  J Biol Chem       Date:  1982-03-25       Impact factor: 5.157

8.  Phospholipid-binding properties of bovine factor V and factor Va.

Authors:  J W Bloom; M E Nesheim; K G Mann
Journal:  Biochemistry       Date:  1979-10-02       Impact factor: 3.162

9.  Isolation, molecular cloning, and partial characterization of a novel carboxypeptidase B from human plasma.

Authors:  D L Eaton; B E Malloy; S P Tsai; W Henzel; D Drayna
Journal:  J Biol Chem       Date:  1991-11-15       Impact factor: 5.157

10.  Monitoring of hemostasis parameters during coronary thrombolysis with recombinant tissue-type plasminogen activator.

Authors:  D C Stump; E J Topol; A B Chen; A Hopkins; D Collen
Journal:  Thromb Haemost       Date:  1988-04-08       Impact factor: 5.249
View more
  2 in total

1.  Thrombin-activatable fibrinolysis inhibitor is activated in vivo in a baboon model of Escherichia coli induced sepsis.

Authors:  Paul Y Kim; Paula Y G Kim; Fletcher B Taylor; Michael E Nesheim
Journal:  J Thromb Thrombolysis       Date:  2012-05       Impact factor: 2.300

2.  Serum-Mediated Cleavage of Bacillus anthracis Protective Antigen Is a Two-Step Process That Involves a Serum Carboxypeptidase.

Authors:  David L Goldman; Edward Nieves; Antonio Nakouzi; Johanna Rivera; Ei Ei Phyu; Than Htut Win; Jacqueline M Achkar; Arturo Casadevall
Journal:  mSphere       Date:  2018-06-27       Impact factor: 4.389
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.